Biosimilars Access and Affordability Act

Official title: To amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.

1. house
3. senate
5. president

Introduced September 28, 2026 by Nicholas A. Langworthy · Last progress September 28, 2026